Cohen’s classic study on statistical power (Cohen, 1962) showed that studies in the 1960 volume of the Journal of Abnormal and Social Psychology lacked sufficient power to detect anything other than large effects (r ~ 0.60). Sedlmeier and Gigerenzer (Sedlmeier & Gigerenzer, 1989) conducted a similar analysis on studies in the 1984 volume and found that, if anything, the situation had worsened. Recently, Button and colleagues showed that the average power of neuroscience studies is probably around 20% (Button et al., 2013b). Clearly repeated exhortations that researchers should “pay attention to the power of their tests rather than … focus exclusively on the level of significance” (Sedlmeier & Gigerenzer, 1989) have failed. Here we consider why this might be so. One reason might be a lack of appreciation of the importance of statistical power within a null hypothesis significance testing (NHST) framework. NHST grew out of the distinct statistical theories of Fisher (Fisher, 1955), and Neyman and Pearson (Rucci & Tweney, 1980). From Fisher we take the concept of null hypothesis testing, and from Neyman-Pearson the concepts of Type I (α) and Type II error (β). Power is a concept arising from Neyman-Pearson theory, and reflects the likelihood of correctly rejecting the null hypothesis (i.e., 1- β). However, the hybrid statistical theory typically used leans most heavily on Fisher’s concept of null hypothesis testing. Sedlmeier and Gigerenzer (1989) argued that a lack of understanding of these distinctions partly explained the lack of consideration of statistical power; while we (nominally, at least) adhere to a 5% Type I error rate, we pay little attention to the Type II error rate, despite the need to consider both when evaluating whether a research finding is likely to be true (Button et al., 2013b). Another reason might be the incentive structures within which scientists operate. Scientists are human and therefore will respond (consciously or unconsciously) to incentives; when personal success (e.g., promotion) is associated with the quality and (critically) the quantity of publications produced, it makes more sense to use finite resources to generate as many publications as possible. A single transformative study in a highly-regarded journal might confer the most prestige, but this is a high-risk strategy – the experiment may not produce the desired (i.e., publishable) results, or the journal may not accept it for publication (Sekercioglu, 2013). A safer strategy might be to “salami-slice” one’s resources to generate more studies which, with sufficient analytical flexibility (Simmons, Nelson, & Simonsohn, 2011), will almost certainly produce a number of publishable studies (Sullivan, 2007). There is some support for the second reason. Studies published in some countries may over-estimate true effects more than those published in other countries (Fanelli & Ioannidis, 2013; Munafo, Attwood, & Flint, 2008). This may be because, in certain countries, publication in even medium-rank journals confers substantial direct financial rewards on the authors (Shao & Shen, 2011), which may in turn be related to over-estimates of true effects (Pan, Trikalinos, Kavvoura, Lau, & Ioannidis, 2005). Authors may therefore (consciously or unconsciously) conduct a larger number of smaller studies, which are still likely to generate publishable findings, rather than risk investing their limited resources in a smaller number of larger studies. However, to the best of our knowledge, the first possible reason has not been systematically explored. We therefore surveyed studies published recently in a high-ranking psychology journal, and contacted authors to establish the rationale used for deciding sample size (see Supplementary Material). This indicated that approximately one third held beliefs that would serve, on average, to reduce statistical power (see Table 1). In particular, they used accepted norms within their area of research to decide on sample size, in the belief that this would be sufficient to replicate previous results (and therefore, presumably, to identify new findings). Given empirical evidence for a high prevalence of findings close to the p = 0.05 threshold (Masicampo & Lalande, 2012), this belief is likely to be unwarranted. If an experiment finds an effect with p ~ 0.05, and we assume the effect size observed is accurate, then if we repeat the experiment with the same sample size we will on average replicate that finding only 50% of the time (see Supplementary Material). In reality, power will be much lower than 50% because the effect size estimate observed in the original estimate is probably an over-estimate (Simonsohn, 2013). However, in our survey, over one third of respondents inaccurately believed that in this scenario the finding would replicate over 80% of the time (see Supplementary Material). Table 1 Beliefs about sample size and statistical power. There are unlikely to be simple solutions to the continued lack of appreciation of statistical power. One reason for pessimism, as we have shown, is that these concerns are not new; occasional discussion of these issues has not led to any lasting change. Structural change may be required, including more rigorous enforcement by journals and editors of guidelines which are often found in instructions for authors, but not always followed. Recently, Nature introduced a submission checklist for life sciences articles, which includes a requirement that sample size be justified (http://www.nature.com/authors/policies/checklist.pdf). Other journals are introducing novel submission formats which place greater emphasis on study design (including statistical power), rather than results, including Registered Reports at Cortex, and Registered Replication Reports at Perspectives on Psychological Science. The poor reproducibility of scientific findings continues to be a cause of major concern. Small studies with low statistical power contribute to this problem (Bertamini & Munafo, 2012; Button et al., 2013b), and arguments in defence of “small-scale science” (Quinlan, 2013) overlook the fact that larger studies protect against inferences from trivial effect sizes by allowing a better estimation of the magnitude of true effects (Button et al., 2013a). Reasons to resist NHST, and in particular the dichotomous interpretation of p-values, have been well-rehearsed (Sterne & Davey Smith, 2001), and alternative approaches, such as focusing on effect size estimation or implementing Bayesian approaches do exist. However, while NHST remains the dominant model for statistical inference, we should ensure that it is appropriately used.
No takes yet. Share an insight, caveat, or question.
Vankov et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: